Azacitidine as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Objective There are no established salvage therapies for relapsed myeloid malignancies after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Azacitidine (AZA) has been reported as a promising treatment in such cases. Methods We conducted a retrospective analysis of patients at our in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Advances in cell and gene therapy 2019-07, Vol.2 (3), p.n/a
Hauptverfasser:	Ozawa, Takayuki, Fuji, Shigeo, Kawashima, Ichiro, Sueki, Yuki, Hagihara, Masao, Handa, Naoko, Ito, Reiko, Yamashita, Tomoko, Kikuchi, Yuji, Ohwada, Akira, Matsuura, Yasuhiro, Yoshifuji, Kota, Tanaka, Takashi, Inamoto, Yoshihiro, Kurosawa, Saiko, Kim, Sung‐Won, Fukuda, Takahiro
Format:	Artikel
Sprache:	eng
Schlagworte:	acute myeloid leukemia allogeneic stem cell transplantation azacitidine myelodysplastic syndrome salvage therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!